British American Tobacco vs Altria: Which High-Yield Dividend Stock Is the Better Buy

For a retirement-focused investor weighing high-yield tobacco names, the question is direct: British American Tobacco (NYSE:BTI | BTI Price Prediction) or Altria Group (NYSE:MO), which screens better for income investors right now? Both throw off cash, both trade at single-digit-to-low-teens forward earnings, and both are racing to replace shrinking combustible volumes with nicotine pouches, vapor, and heated tobacco. But when you line them up on the metrics that actually matter for a retiree cashing checks, one name comes out ahead.

Round 1: The Income Stream

Altria pays a forward annualized dividend of $4.44 per share on a share price of $70.17, yielding 6.10%. It just declared a raise to $1.11 per share quarterly, with the next check landing October 9, 2026. BTI yields 5.83% on a $56.47 ADR, with a forward annualized payout of $3.34.

Two practical differences matter. BTI declares its full-year dividend once (in sterling) and pays it in four equal quarterly installments of 61.26p, so the dollar amount you actually receive fluctuates with the pound. Altria declares and pays in dollars, no FX friction, no ADR fee. The UK does not withhold on ADR dividends, so tax treatment is roughly a wash, but the currency exposure is real. Winner: MO, on higher yield and a cleaner, dollar-denominated cash flow.

Round 2: Dividend Durability and Track Record

Altria just delivered its 60th dividend increase in the past 56 years and returned $8 billion to shareholders in 2025 combined. Coverage looks tight but works: FY2026 adjusted EPS guidance of $5.56 to $5.72 against a $4.44 annualized payout. The uncomfortable footnote is negative stockholders’ equity of -$3.21 billion, the accounting price of sustained buybacks and dividends.

BTI generated $6.342 billion in operating cash flow in FY2025, is targeting operating cash flow conversion above 95%, and completed a £1.1 billion buyback alongside a £1.3 billion 2026 program. Its FY2025 dividend was 245.04p, a 2.0% increase, versus Altria’s 3.9% hike in August 2025. BTI has stronger balance-sheet optics; Altria has the longer, more mechanical growth streak that retirees actually plan around. Winner: MO, on sheer consistency and the frequency of raises.

Round 3: Business Trajectory and Risk

This is where the case flips. BTI’s Modern Oral segment grew 47.4% in FY2025, Velo Plus revenue in the U.S. jumped over 310%, and management guides to 5% to 8% adjusted EPS growth in 2026. Altria’s on! category share fell 4.2 points to 13.4%, its NJOY ACE import ban is not reversing this year, and domestic cigarette volumes fell roughly 10.0% for full year 2025. Altria guides just 2.5% to 5.5% EPS growth. BTI also runs at a lower beta of 0.114 versus 0.494 for Altria, and trades at a cheaper forward P/E of 11 against Altria’s 12. Winner: BTI, on growth, diversification, and valuation.

Verdict

Altria has already run. It is up 27.6% year to date and 122.89% over ten years, while BTI has returned 2.58% YTD. For a retiree who wants the biggest dollar check, the most predictable schedule, and no currency noise, Altria screens best on income durability (the kind of setup we build around in our free dividend ladder guide, here). For everyone else, BTI screens better today on the fundamentals: cheaper, faster-growing, less volatile, with a smokeless portfolio that is gaining share while Altria’s is losing it. Overall winner: BTI, and the gap widens the longer your horizon.

Contact [email protected] for any questions or corrections.